This grant will explore a cell therapy approach for the treatment of osteoarthritis via delivery of human mesenchymal stem cells (MSC) and adipose-derived stem cells (ASC) in the form of three-dimensional hydrogels.

L2P Labs will aim to combine the use of hydrogel, stem cells, and ultrasound therapy to develop a new treatment for osteoarthritis. These approaches have shown promise alone and their combination will pave the way for a new therapy to reduce Osteoarthritisassociated pain and improve mobility.


https://www.businesswire.com/news/home/20231027595379/en/L2P-Research-Labs-Awarded-NIH-SBIR-Grant-for-Arthritis-Musculoskeletal-and-Skin-Diseases-Research